Oxford University’s RECOVERY clinical trial has found that low-dose dexamethasone increases the chance of survival in patients with COVID-19 who require respiratory support. In the study, the drug ...
Weekly demand in the U.S. is up more than 600%. Last week, a study in the U.K. found that dexamethasone, a common steroid, increased survival in severely ill COVID-19 patients who needed help ...
Incidence of infections in clinical trials of treatments for relapsed/refractory multiple myeloma: Systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback